Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Depreciation & Amortization (CF): 2009-2022

Historic Depreciation & Amortization (CF) for Innoviva (INVA) over the last 13 years, with Sep 2022 value amounting to $12.5 million.

  • Innoviva's Depreciation & Amortization (CF) rose 20.54% to $12.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $30.0 million, marking a year-over-year increase of 44.44%. This contributed to the annual value of $13.8 million for FY2021, which is 0.06% down from last year.
  • Latest data reveals that Innoviva reported Depreciation & Amortization (CF) of $12.5 million as of Q3 2022, which was up 248.29% from $3.6 million recorded in Q2 2022.
  • Over the past 5 years, Innoviva's Depreciation & Amortization (CF) peaked at $12.5 million during Q3 2022, and registered a low of $3.3 million during Q3 2019.
  • Over the past 3 years, Innoviva's median Depreciation & Amortization (CF) value was $3.5 million (recorded in 2020), while the average stood at $5.1 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first fell by 4.27% in 2019, then spiked by 199.80% in 2021.
  • Innoviva's Depreciation & Amortization (CF) (Quarterly) stood at $3.5 million in 2018, then grew by 0.17% to $3.5 million in 2019, then dropped by 0.46% to $3.5 million in 2020, then soared by 199.80% to $10.4 million in 2021, then increased by 20.54% to $12.5 million in 2022.
  • Its Depreciation & Amortization (CF) stands at $12.5 million for Q3 2022, versus $3.6 million for Q2 2022 and $3.5 million for Q1 2022.